Pacira Biosciences, Inc. (PCRX) SEC Filings — 2024
15 SEC filings for Pacira Biosciences, Inc. (PCRX) in 2024.
Filings
- Pacira BioSciences Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
- Pacira BioSciences Appoints New CMO, Director — 8-K · Oct 21, 2024
- Pacira BioSciences Reports Director/Officer Changes — 8-K · Sep 27, 2024
- Pacira BioSciences to be Acquired for $3.3 Billion — 8-K · Sep 9, 2024
- Pacira BioSciences Files 8-K — 8-K · Aug 9, 2024
- Pacira BioSciences Files Q2 2024 10-Q — 10-Q · Jul 30, 2024
- Pacira BioSciences Appoints New CEO, Dr. David Stack — 8-K · Jun 13, 2024
- Pacira BioSciences Files 8-K on Financial Obligations and Equity Sales — 8-K · May 14, 2024
- Pacira BioSciences Enters Material Definitive Agreement — 8-K · May 8, 2024
- Pacira BioSciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Pacira BioSciences Files Definitive Proxy Statement — DEF 14A · Apr 22, 2024
- Pacira BioSciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- Pacira Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Amends Pacira BioSciences Stake (12th Amendment) — SC 13G/A · Jan 19, 2024
- Pacira BioSciences Files 8-K on Operations & Financial Condition — 8-K · Jan 4, 2024